Literature DB >> 17960026

SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL.

Laurent Yvan-Charvet1, Tamara A Pagler, Nan Wang, Takafumi Senokuchi, May Brundert, Hongna Li, Franz Rinninger, Alan R Tall.   

Abstract

This study compares the roles of ABCG1 and scavenger receptor class B type I (SR-BI) singly or together in promoting net cellular cholesterol efflux to plasma HDL containing active LCAT. In transfected cells, SR-BI promoted free cholesterol efflux to HDL, but this was offset by an increased uptake of HDL cholesteryl ester (CE) into cells, resulting in no net efflux. Coexpression of SR-BI with ABCG1 inhibited the ABCG1-mediated net cholesterol efflux to HDL, apparently by promoting the reuptake of CE from medium. However, ABCG1-mediated cholesterol efflux was not altered in cholesterol-loaded, SR-BI-deficient (SR-BI(-/-)) macrophages. Briefly cultured macrophages collected from SR-BI(-/-) mice loaded with acetylated LDL in the peritoneal cavity did exhibit reduced efflux to HDL. However, this was attributable to reduced expression of ABCG1 and ABCA1, likely reflecting increased macrophage cholesterol efflux to apolipoprotein E-enriched HDL during loading in SR-BI(-/-) mice. In conclusion, cellular SR-BI does not promote net cholesterol efflux from cells to plasma HDL containing active LCAT as a result of the reuptake of HDL-CE into cells. Previous findings of increased atherosclerosis in mice transplanted with SR-BI(-/-) bone marrow probably cannot be explained by a defect in macrophage cholesterol efflux.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960026     DOI: 10.1194/jlr.M700200-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  20 in total

Review 1.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  The ins and outs of lipid efflux.

Authors:  Stefan Lorkowski
Journal:  J Mol Med (Berl)       Date:  2008-02       Impact factor: 4.599

3.  Apolipoproteins A-I, A-II and E are independently distributed among intracellular and newly secreted HDL of human hepatoma cells.

Authors:  Baiba K Gillard; Hu-Yu Alice Lin; John B Massey; Henry J Pownall
Journal:  Biochim Biophys Acta       Date:  2009-07-25

Review 4.  Protein mediators of sterol transport across intestinal brush border membrane.

Authors:  J Mark Brown; Liqing Yu
Journal:  Subcell Biochem       Date:  2010

Review 5.  Cholesterol in platelet biogenesis and activation.

Authors:  Nan Wang; Alan R Tall
Journal:  Blood       Date:  2016-02-29       Impact factor: 22.113

6.  Scavenger receptor SR-BI in macrophage lipid metabolism.

Authors:  Ailing Ji; Jason M Meyer; Lei Cai; Akinwunmi Akinmusire; Maria C de Beer; Nancy R Webb; Deneys R van der Westhuyzen
Journal:  Atherosclerosis       Date:  2011-04-09       Impact factor: 5.162

7.  Emerging roles for cholesterol and lipoproteins in lung disease.

Authors:  Kymberly M Gowdy; Michael B Fessler
Journal:  Pulm Pharmacol Ther       Date:  2012-06-15       Impact factor: 3.410

8.  Cholesterol efflux analyses using stable isotopes and mass spectrometry.

Authors:  Robert J Brown; Fei Shao; Angel Baldán; Carolyn J Albert; David A Ford
Journal:  Anal Biochem       Date:  2012-10-13       Impact factor: 3.365

9.  ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet.

Authors:  Naoki Terasaka; Shuiqing Yu; Laurent Yvan-Charvet; Nan Wang; Nino Mzhavia; Read Langlois; Tamara Pagler; Rong Li; Carrie L Welch; Ira J Goldberg; Alan R Tall
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

10.  Enhancing apolipoprotein A-I-dependent cholesterol efflux elevates cholesterol export from macrophages in vivo.

Authors:  Nigora Mukhamedova; Genevieve Escher; Wilissa D'Souza; Urbain Tchoua; Angela Grant; Zigmund Krozowski; Michael Bukrinsky; Dmitri Sviridov
Journal:  J Lipid Res       Date:  2008-07-12       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.